Eric Beard

GISH Biomedical, Inc. designs, manufactures and markets innovative disposable medical devices for cardiovascular surgery, with a focus on the Perfusionist. The GISH product portfolio also includes targeted solutions for vascular access and orthopedics. All GISH products are single use disposable products or have a disposable component. The company's principal products include oxygenators and oxygenator systems, blood reservoirs, cardioplegia delivery systems, custom cardiovascular tubing systems, central venous access catheters and ports, and blood recovery devices for post-operative use in orthopedic surgeries. With a manufacturing facility and offices in Rancho Santa Margarita, California, GISH markets its products worldwide through a combination of direct sales representatives and specialty medical distributors. GISH has been at the forefront of the design and manufacturing of hospital based and operating room medical devices for over 25 years. From simple sets to complex circuits for open heart surgery, precision and quality in manufacturing is what you can rely on from GISH.

EOS Imaging SA engages in the development and marketing of imaging and imaged-based solutions for diagnosing, treating, and monitoring common musculoskeletal pathologies. It operates through the France and North America geographical segments. The firm trademarks include EOSedge, sterEOS, spineEOS, hipEOS, and kneeEOS. The company was founded by Georges Charpak on February 8, 1989 and is headquartered in Paris, France.

LivaNova Holding USA, Inc. develops medical technologies for cardiac surgery. It offers innovative therapies for cardiac rhythm dysfunctions, interventional cardiology, and chronic kidney diseases. The firm's products include cardiopulmonary equipment, oxygenators and reservoirs, arterial filters, pediatric systems, and centrifugal devices. The company was founded in 1999 and is headquartered in Arvada, CO.

Cellnovo Ltd. manufactures diabetes management devices. The private company is based in Bridgend, UK. The British company was founded by Julian Shapley. The CEO is Sophie Baratte.

Invizius Ltd. develops application for dialysis patients. It offers hemo compatibility for dialyzers. The company was founded by Andrew Herbert on January 26, 2018 and is headquartered in Edinburgh, the United Kingdom.

Cellnovo Group SA was a medical technology company, which specialized in diabetes. The company developed and marketed the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. It products portfolio included system, switch, pump therapy, and patient stories. The company was founded by Julian Shapley on December 15, 2014 and was headquartered in Paris, France.